AWA Point
Tag: patents
Data Requirements for Patenting Biotech/Pharma Inventions in China and the EU
This interactive webinar considers the filing and post-filing data requirements for biotechnology and pharmaceutical-related inventions in China and
How to fast track patent applications in China through prioritised patent examination
Xiaofan Chen from AWA Asia’s patent team in Beijing looks at how applicants can streamline the examination of certain
Fine Tuning Commercial IP Portfolios: Value, Cost Savings and Investing in the Future
There has never been a better time to review your company’s IP portfolio than in the current business climate.
Faster and Stronger Protection for New Technologies in China
There have been a series of amendments to China’s Patent Examination Guidelines over the past year, especially regarding the
Valuation for Technology & IP Transactions in Good Times & Bad
Transactions involving new technologies and their related intangible assets have grown steadily. Restarting the world’s economic engines after the
Intellectual Property and Domains for Start-ups and Scaleups
Explores the essentials when it comes to IP and domain names for start-ups and scaleups. An expert panel focuses
China becomes top international patent filer
China filed 58,990 applications through WIPO’s Patent Cooperation Treaty (PCT) System last year, ending the US’s stronghold on the
Clarifying the patentability of medical use inventions in China
At the end of 2019, the new Coronavirus (2019-nCoV) emerged. It has gone on to infect millions of people
EPO rules plants and animals exclusively obtained by essentially biological processes not patentable
It has been clear that essentially biological processes for the production of plants or animals are explicitly excluded from
What patent protection does Gilead’s COVID-19 treatment Remdesivir have?
On 29 April 2020 Gilead announced that its drug Remdesivir has a positive effect in the treatment of COVID-19